Navigation Links
Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.
Date:12/17/2009

RALEIGH, N.C., Dec. 17 /PRNewswire/ -- Pharmaceutical Institute today announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.

Pharmaceutical Institute is a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance. Financial terms of the agreement were not disclosed.

"We are very pleased with the acquisition of these assets. GeneEd invested more than 10 years and $15 million in their creation, and the content they created is second to none," said John Campbell, CEO of Campbell Alliance. "Over 25 of the world's leading pharma and biotech companies are already using these materials with great success."

As part of the agreement, Pharmaceutical Institute acquired 155 e-courses, including:

  • 135 e-courses in key therapeutic areas, including cardiovascular, diabetes, respiratory, gastrointestinal, muscular skeletal, kidney, infection, oncology, central nervous system, pain and anesthesia, urinary, and metabolism.
  • 12 e-courses in biopharmaceutical technology, including human gene therapy, genomics, combinatorial chemistry, computer-assisted drug design, immunity and disease, bioinformatics, advanced bioinformatics, microarrays, SNPs, methods in microbiology, and microarray informatics.
  • 8 e-courses in clinical trial regulation, including biostatistics, adverse events reporting, good clinical practices, good laboratory practices, and 21 CFR part 11 (electronic records and signatures).

"Pharmaceutical Institute has focused its efforts on building an extensive library of e-course materials for the pharmaceutical and biotech industry. The resources we have acquired from GeneE
'/>"/>

SOURCE Pharmaceutical Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
2. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
3. KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
4. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
5. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
6. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
7. GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms
8. New Report Grades Sustainability Reporting of Top Pharmaceutical Companies
9. Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications
10. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
11. Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- IP Shakti, LLC, today announced that it has changed its ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... signifies our transformation into a company focused on patent claim ... claim validity." ... platform, the Company commenced a corporate re-branding initiative in order ...
(Date:8/28/2015)... Denmark and ATLANTA , August ... the US Food and Drug Administration (FDA) cleared the MagVita ... in adult patients who have failed to receive satisfactory improvement ... a non-invasive technique for stimulating neural tissue in the part ... Disorder. The procedure has been proven safe and effective and ...
(Date:8/28/2015)... India , August 28, 2015 ... Oils), Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ... , Asia-Pacific , and Rest of the ... MarketsandMarkets, The global market for Eubiotics was valued at USD ... 7.05 Billion by 2020, at a CAGR of 7.4% from ...
Breaking Medicine Technology:IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5
... Fla., Dec. 2 Jupiter Medical Center ... into its imaging program, the new Signa HDx 1.5T MRI ... of the human body with increased speed, better resolution and ... for patients with renal dysfunction. This results in shorter ...
... , , NEW YORK, Dec. 2 ... five veteran attorneys, led by Neil H. Ekblom, LeClairRyan,s ... in the New York market. Mr. Ekblom, a former ... claims. , The New York team adds to an ...
Cached Medicine Technology:Jupiter Medical Center Announces New High-Definition MRI System 2Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 2Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 3
(Date:8/29/2015)... ... ... On September 30, 2015, the Career and Transfer Center (CTC) at ... Community Colleges , will be hosting a Job Expo to provide a professional, open ... The Expo has expanded to much more than just a typical job and career ...
(Date:8/29/2015)... PA (PRWEB) , ... August 29, 2015 , ... ... said one of two inventors from Miller Place, N.Y. "I specialize in manual ... and discomfort. In addition, it can be used for additional muscle dysfunction throughout ...
(Date:8/29/2015)... CA (PRWEB) , ... August 29, 2015 , ... Dr. ... a mission. His mission is to increase acceptance of the chiropractic field in ... medications that further debilitate them. Although Chiropractic was made available to the VA ...
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 particle backdrops designed ... of unique footage that users can shrink and stretch in the Final Cut Pro ... can customize color, brightness, scale, speed, range, and flare attributes with intuitive controls found ...
(Date:8/29/2015)... ... ... The popular television program VOICES IN AMERICA, hosted by legendary star of ... an entire short segment to the subject of diabetes. Diabetes is a debilitating health ... basis, but recent advancements in medical science may prove to be a significant breakthrough ...
Breaking Medicine News(10 mins):Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:The Patriot Project brings Chiropractic Care to the Armed Forces and their Families - Rapid Release Technology Joins the Effort to Recruit more Doctors to Pledge 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2
... Socially isolated men may have increased levels of blood marker ... from Harvard School of Public Health say that it may ... to be socially connected. A well-connected man will have a ... connection to the immediate society like the workplace, or the ...
... cardiovascular diseases for better in as early as ... Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology. ... Mediterranean type diet may bring about serious changes ... have a high risk of cardiovascular disease. ...
... employees may be less health conscious and may be spending ... ,New research suggests that working full time leads to a ... term. People who work full time have less time for ... games or sit in front of the computer. These seem ...
... a recent study researchers say cholesterol may be actually needed ... however researchers also say that too much of it could ... arteries, where it builds up as plaque and can cause ... ACAT2 may be to blame for the build-up. ACAT2 is ...
... cohosh, an herb, is often used for treatment of menopausal ... chemotherapy taken for breast cancer the results may be altered. ... report have said that alternative medication or self medication taken ... to chemotherapy. Most of the time doctors are not even ...
... have been able to successfully diagnose autism in infants ... to systematically document early signs of autism in children ... confirmed the diagnosis in a follow up study, till ... involved development of computerized visual orienting task, standardized measures ...
Cached Medicine News:
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
... a 1-step, hand-held, point-of-care device for the qualitative ... urine. The TOX/See device can detect up ... in 3 to 8 minutes and requires only ... is individually packaged to maximize convenience and ease ...
Medicine Products: